Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 64

Results For "IMI"

5328 News Found

Takara Bio and Resistomap forge deal to speed up global fight against superbugs
News | April 19, 2026

Takara Bio and Resistomap forge deal to speed up global fight against superbugs

The collaboration combines Takara Bio’s large-scale testing technology with Resistomap’s data-driven AMR intelligence


Cipla receives two observations following USFDA inspection at Goa facility
Drug Approval | April 18, 2026

Cipla receives two observations following USFDA inspection at Goa facility

The company stated that it will work closely with the regulator to address the observations within the stipulated timeframe


Experts endorse low-sodium salt substitutes to cut India’s hypertension burden
Public Health | April 18, 2026

Experts endorse low-sodium salt substitutes to cut India’s hypertension burden

Consensus calls for nationwide adoption of potassium-enriched salt to reduce cardiovascular disease risk


Department of Biotechnology invites applications for DBT Research Associateship 2025–26
Biotech | April 18, 2026

Department of Biotechnology invites applications for DBT Research Associateship 2025–26

Postdoctoral fellowship aims to build skilled talent pool in biotechnology and life sciences


Department of Pharmaceuticals seeks proposals for SPEL study to strengthen logistics ecosystem
Supply Chain | April 18, 2026

Department of Pharmaceuticals seeks proposals for SPEL study to strengthen logistics ecosystem

Bidding window open till May 15; study to map costs and bottlenecks across pharma supply chains


NIFTY Pharma shows stable trend amid cautious market sentiment
News | April 17, 2026

NIFTY Pharma shows stable trend amid cautious market sentiment

Muted movement reflects consolidation phase as investors await earnings triggers


Morepen Laboratories secures fourth consecutive USFDA ‘NIL 483’ inspection
Drug Approval | April 17, 2026

Morepen Laboratories secures fourth consecutive USFDA ‘NIL 483’ inspection

Zero-observation outcomes strengthen global credibility and accelerate CDMO ambitions


Experts push for preventive, equitable haemophilia care at IHC X Summit
Healthcare | April 17, 2026

Experts push for preventive, equitable haemophilia care at IHC X Summit

The national platform brought together healthcare professionals, patient advocates, and stakeholders


NIPER Mohali, Novartis Healthcare sign pact to boost pharma R&D innovation
R&D | April 16, 2026

NIPER Mohali, Novartis Healthcare sign pact to boost pharma R&D innovation

The grant backed by Novartis to strengthen academia-industry collaboration across all seven NIPERs


Aurigene, Alveus advance obesity pipeline with ALV-200 candidate nomination
R&D | April 16, 2026

Aurigene, Alveus advance obesity pipeline with ALV-200 candidate nomination

The collaboration combines Alveus’ expertise in metabolic biology and therapeutic strategy with Aurigene’s integrated discovery capabilities